CTKB
Cytek Biosciences, Inc. NASDAQ Listed Jul 23, 2021$3.77
-5.28%
vs $3.98
Mkt Cap $481.6M
52w Low $2.95
28.0% of range
52w High $5.88
50d MA $4.24
200d MA $4.48
P/E (TTM)
-7.2x
EV/EBITDA
—
P/B
1.4x
Debt/Equity
0.1x
ROE
-19.5%
P/FCF
-54.9x
RSI (14)
36.70
ATR (14)
$0.23
Beta
1.28
50d MA
$4.24
200d MA
$4.48
Avg Volume
1.8M
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
47215 Lakeview Boulevard · Fremont, CA 94538 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | -0.08 | -0.12 | -50.0% | 4.92 | -8.7% | -6.3% | -10.6% | -1.9% | -8.9% | -8.7% | — |
| Feb 26, 2026 | AMC | -0.02 | -0.01 | +50.0% | 4.40 | -3.6% | +1.8% | -1.1% | +0.2% | -0.7% | -0.7% | — |
| Nov 5, 2025 | AMC | 0.01 | -0.01 | -200.0% | 4.01 | +6.5% | +13.2% | +1.8% | +2.8% | +0.8% | +0.4% | — |
| Aug 6, 2025 | AMC | -0.02 | 0.01 | +150.0% | 3.89 | +0.0% | +5.7% | -1.9% | -6.0% | +6.3% | +3.5% | — |
| May 8, 2025 | AMC | -0.04 | -0.09 | -125.0% | 3.79 | -18.2% | -22.7% | +3.1% | -1.3% | -8.4% | -1.8% | — |
| Feb 27, 2025 | AMC | 0.05 | 0.07 | +40.0% | 4.81 | -4.4% | -6.7% | -4.2% | +0.2% | +3.7% | -0.2% | — |
| Nov 5, 2024 | AMC | 0.00 | 0.01 | +168.0% | 5.44 | +9.9% | +36.0% | -2.4% | -2.4% | +1.4% | -1.5% | — |
| Aug 6, 2024 | AMC | -0.03 | -0.08 | -166.7% | 5.62 | +1.4% | -9.4% | +6.5% | -3.7% | +0.2% | +2.3% | — |
| May 8, 2024 | AMC | -0.05 | -0.05 | +0.0% | 6.27 | +1.3% | -1.1% | +1.6% | -1.9% | +1.9% | -3.2% | — |
| Mar 13, 2024 | AMC | 0.03 | 0.07 | +133.3% | 6.74 | +0.1% | +1.2% | +1.9% | -2.2% | -1.5% | +0.0% | — |
| Feb 28, 2024 | AMC | 0.03 | 0.07 | +133.3% | 8.74 | +1.8% | -11.9% | +18.8% | -7.4% | -3.9% | -13.1% | — |
| Nov 7, 2023 | AMC | -0.33 | 0.01 | +103.0% | 4.45 | -14.6% | +12.4% | -4.5% | +2.6% | +1.2% | +10.3% | — |
| Aug 8, 2023 | AMC | -0.01 | 0.01 | +200.0% | 8.92 | -0.2% | +0.8% | +1.2% | +3.2% | -5.0% | -2.4% | — |
| May 9, 2023 | AMC | -0.01 | -0.03 | -100.0% | 11.67 | -7.0% | -24.0% | -8.4% | -7.8% | -2.8% | -5.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8 | TD Cowen | Maintains | Buy → Buy | — | $5.50 | $5.49 | -0.2% | -1.3% | +0.4% | +6.4% | -1.7% | -2.5% |
| Nov 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $4.75 | $4.69 | -1.3% | +0.8% | +0.4% | -5.0% | +20.4% | -3.8% |
| May 28 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $2.57 | $2.55 | -0.8% | -3.1% | +4.0% | +6.9% | +2.2% | +0.7% |
| May 12 | Goldman Sachs | Maintains | Sell → Sell | — | $2.93 | $3.06 | +4.4% | +3.1% | -1.3% | -8.4% | -1.8% | -0.4% |
| Mar 19 | Stephens & Co. | Maintains | Overweight → Overweight | — | $4.24 | $4.20 | -0.9% | -0.5% | -3.8% | +3.4% | +0.5% | -2.8% |
| Mar 4 | Piper Sandler | Maintains | Overweight → Overweight | — | $4.30 | $4.22 | -1.9% | +0.2% | +3.7% | -0.2% | +1.6% | -3.8% |
| Nov 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $7.05 | $6.99 | -0.9% | +1.4% | -1.5% | -3.7% | -5.3% | -7.3% |
| Aug 13 | Piper Sandler | Maintains | Overweight → Overweight | — | $5.23 | $5.29 | +1.1% | +2.3% | -0.9% | +2.1% | +1.5% | +0.7% |
| May 13 | Piper Sandler | Maintains | Overweight → Overweight | — | $6.30 | $6.30 | +0.0% | -1.9% | +1.9% | -3.2% | +1.3% | -1.3% |
| Mar 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $8.14 | $8.08 | -0.7% | -13.1% | +1.3% | -0.6% | +1.4% | -5.0% |
| Feb 29 | Goldman Sachs | Maintains | Buy → Buy | — | $8.74 | $8.90 | +1.8% | -11.9% | +18.8% | -7.4% | -3.9% | -13.1% |
| Nov 9 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $5.00 | $5.01 | +0.2% | -4.5% | +2.6% | +1.2% | +10.3% | +4.4% |
| Oct 24 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $4.62 | $4.55 | -1.5% | +2.8% | -5.3% | +2.2% | -5.9% | -5.3% |
| Oct 16 | Piper Sandler | Maintains | Overweight → Overweight | — | $5.02 | $5.09 | +1.4% | -4.0% | +6.4% | -5.7% | -2.3% | -1.5% |
| May 11 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $8.87 | $8.84 | -0.3% | -8.4% | -7.8% | -2.8% | -5.4% | -0.4% |
| May 10 | Goldman Sachs | Maintains | Buy → Buy | — | $11.67 | $10.85 | -7.0% | -24.0% | -8.4% | -7.8% | -2.8% | -5.4% |
| Mar 7 | Piper Sandler | Maintains | Overweight → Overweight | — | $10.15 | $10.15 | +0.0% | -1.5% | -1.7% | -4.6% | -2.9% | +3.6% |
| Mar 2 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $9.49 | $9.33 | -1.7% | +1.6% | +10.1% | -4.3% | -1.5% | -1.7% |
| Mar 2 | Goldman Sachs | Maintains | Buy → Buy | — | $9.49 | $9.33 | -1.7% | +1.6% | +10.1% | -4.3% | -1.5% | -1.7% |
| Aug 18 | Piper Sandler | Maintains | Overweight → Overweight | — | $14.08 | $14.00 | -0.6% | -0.1% | -2.6% | -4.0% | +2.2% | -0.5% |
| Aug 12 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $14.83 | $15.00 | +1.1% | +0.5% | +0.5% | -5.5% | -0.5% | -0.1% |
| Aug 11 | Goldman Sachs | Maintains | Buy → Buy | — | $15.45 | $15.76 | +2.0% | -4.0% | +0.5% | +0.5% | -5.5% | -0.5% |
| Jul 14 | Goldman Sachs | Maintains | Buy → Buy | — | $11.65 | $11.51 | -1.2% | +2.4% | +0.8% | -4.7% | +2.6% | +1.9% |
| May 16 | Piper Sandler | Maintains | Overweight → Overweight | — | $9.38 | $9.28 | -1.1% | +5.5% | +2.0% | -4.5% | +1.8% | -1.1% |
| May 13 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $8.13 | $8.37 | +3.0% | +15.4% | +5.5% | +2.0% | -4.5% | +1.8% |
| May 12 | Goldman Sachs | Maintains | Buy → Buy | — | $7.41 | $7.52 | +1.5% | +9.7% | +15.4% | +5.5% | +2.0% | -4.5% |
| Apr 13 | Goldman Sachs | Maintains | Buy → Buy | — | $10.21 | $10.20 | -0.1% | +3.3% | -1.7% | +0.5% | -0.1% | -2.8% |
| Feb 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $14.47 | $14.89 | +2.9% | +3.7% | -0.1% | -1.1% | -6.0% | -3.4% |
No insider trades available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Millennium Management | 6,291,798 | $27M | Added | Mar 2026 |
| 2 | Boston Partners | 5,802,773 | $25M | Added | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 4,762,904 | $21M | New | Mar 2026 |
| 4 | Morgan Stanley | 3,401,970 | $17M | Added | Dec 2025 |
| 5 | Vanguard Portfolio Management Llc | 2,311,858 | $10M | New | Mar 2026 |
| 6 | Brown Capital Management Llc | 1,480,506 | $6M | Reduced | Mar 2026 |
| 7 | Russell Investments Group, Ltd. | 1,359,900 | $6M | Added | Mar 2026 |
| 8 | Bank Of America Corp /de/ | 1,009,054 | $4M | Added | Mar 2026 |
| 9 | Northern Trust Corp | 1,005,193 | $4M | Added | Mar 2026 |
| 10 | Aqr Capital Management Llc | 912,342 | $4M | Added | Mar 2026 |
| 11 | Simcoe Capital Llc | 882,113 | $4M | Added | Mar 2026 |
| 12 | Principal Financial Group Inc | 666,927 | $3M | Added | Dec 2025 |
| 13 | Renaissance Technologies Llc | 676,700 | $3M | — | Mar 2026 |
| 14 | Bank Of New York Mellon Corp | 608,647 | $3M | Reduced | Mar 2026 |
| 15 | Citadel Advisors Llc | 471,392 | $2M | Added | Mar 2026 |
| 16 | Hrt Financial Lp | 414,052 | $2M | Reduced | Mar 2026 |
| 17 | Acadian Asset Management Llc | 398,988 | $2M | Reduced | Mar 2026 |
| 18 | Invesco Ltd. | 388,233 | $2M | Reduced | Mar 2026 |
| 19 | Connor, Clark & Lunn Investment Management Ltd. | 295,636 | $1M | Reduced | Dec 2025 |
| 20 | Tudor Investment Corp | 320,715 | $1M | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$481.6M
Enterprise Value
$227.4M
P/E (TTM)
-7.25x
Forward P/E
—
PEG Ratio
-0.01x
P/B
1.41x
P/S
2.39x
P/FCF
-54.91x
EV/EBITDA
—
Shares Out
127.7M
Financials (TTM)
Revenue
$201.5M
Net Income
-$66.5M
EBITDA
-$17.4M
Free Cash Flow
-$8.8M
Op Cash Flow
-$4.7M
EPS Basic
$-0.52
EPS Diluted
$-0.52
EPS Forward
$-0.21
Gross Margin
51.8%
Op Margin
-20.0%
Net Margin
-33.0%
Balance Sheet
Total Assets
$461.5M
Total Liab.
$119.8M
Total Equity
$341.7M
Cash
$261.5M
LT Debt
$7.3M
Book Value/Sh
$2.68
Debt/Equity
0.10x
Current Ratio
5.04
Quick Ratio
4.42
Returns & Growth
ROE
-19.5%
ROA
-14.4%
ROIC
-10.2%
Rev Growth YoY
+0.5%
EPS Growth YoY
-1030.4%
Price Returns
2W
+24.7%
1M
-8.1%
3M
-6.5%
6M
-25.8%
12M
+51.3%
Technicals
52W High
$5.88
52W Low
$2.95
50d MA
$4.24
200d MA
$4.48
RSI (14)
36.70
ATR (14)
$0.23
Beta
1.28
Avg Volume
1.8M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$6.00
High
$6.00
Low
$6.00
Median
$6.00
Data updated apr 25, 2026 3:41am
· Source: financialmodelingprep.com